Accelerated Stability Modeling for Peptides: a Case Study with Bacitracin
- 474 Downloads
The Accelerated Stability Assessment Program (ASAP) was applied for the first time to a peptide, the antibiotic active pharmaceutical ingredient bacitracin. Bacitracin and its complex with zinc were exposed to temperature and relative humidity conditions from 50 to 80°C and from 0 to 63% for up to 21 days. High-performance liquid chromatography was used to analyze the stressed samples for both degradant formation and loss of the active (bacitracin A) and two inactive isoforms, with identities confirmed by mass spectrometry. These data were then analyzed using a humidity-corrected Arrhenius equation and isoconversion approach to create a shelf-life predicting model for typical storage conditions. Model fitting was found to be good with low residuals in both temperature and relative humidity axes for all parameters examined. The generated model’s predictions for both the native and zinc complex of bacitracin for both formation of the major degradation product (F) and loss of the active isoform (A) were consistent with longer-term measured values at 30°C/53%RH and 40°C/75%RH, validating this approach for accelerating the determination of long-term stability of a peptide.
KEY WORDSaccelerated stability peptide stability solid-state stability stability modeling
The authors would like to acknowledge the following scientists from FreeThink Technologies, who helped considerably on this project: Alisa Waterman, Philip Waterman, Tom Sharp, Michael Grabowski, Nick Sinchuk, and Teslin Botoy.
- 1.International Conference on Harmonization Guideline Q1A(R2): stability testing of new drug substances and drug Products 2003.Google Scholar
- 5.Waterman KC. 2009.Understanding and predicting pharmaceutical product shelf-life. In Huynh-Ba K, editor. Handbook of Stability Testing in Pharmaceutical Development, Springer, p 115–135.Google Scholar
- 6.Waterman KC, Colgan ST. A science-based approach to setting expiry dating for solid drug products. Regul Rapp. 2008;5(7):9–14.Google Scholar
- 13.Shnyrov VL, Zhadan GG. Irreversible thermal denaturation of complex biological structures. 2000;4:351–67.Google Scholar
- 14.Reithmeier H, Dickes M, Winer G, Knoll AG. Accelerated isothermal and non-isothermal stability studies of aqueous protein formulations. Proc Int Symp Control Rel Bioact Mater. 2001;28:896–7.Google Scholar
- 19.United States Pharmacopeia. 2008. Bacitracin Monograph. In USP 31-NF, p 1483–1485.Google Scholar